Except the effective activation of GCV to its toxic metabolite of GCV-3P by MSCs-tk, the intracellular delivery of GCV-3P from MSCs-tk to C6 glioma cells, which mainly relies on GJIC, is also critical for the bystander toxicity to inhibit the growth of C6 glioma cells. This evidence concerns the gene TKT and glioma.